Home > Science > Scientific Presentations

Scientific Presentations

3-Jun-2021	Phelan McDermid Syndrome Foundation - Interview with Neuren Pharmaceuticals about upcoming Phelan-McDermid clinical trial

14-Jul-2020	Publication in Pediatric Neurology: Berry-Kravis E et al., A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome

14-Jul-2020	Poster at 72nd Annual Meeting of American Academy of Neurology
	Trofinetide: a novel approach to Rett syndrome. Neul JL, Percy AK, Benke TA, Berry-Kravis EM, Glaze DG, Jones NE, Youakim JM.

27-Mar-2019	Publication in Neurology®: Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome

23-Jun-2016	Poster at Rettsyndrome.org 2016 Rett Syndrome Symposium
	Improving outcome measures for Rett Syndrome (RTT) clinical trials: Development of CSS/MBA change indexes to assess treatment outcome

22-Jun-2016	Presentation by Daniel Glaze, MD, at Rettsyndrome.org 2016 Rett Syndrome Symposium
	Past, Present and Future: A program to develop and establish Trofinetide as a safe and effective treatment for Rett syndrome

12-May-2016	Presentation at 6th Annual TBI Conference, Washington DC
	A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of NNZ-2566 in Patients with Traumatic Brain Injury

22-Apr-2015	Poster at American Academy of Neurology 2015 Annual Meeting
	NNZ-2566: A Novel, Experimental Treatment for Rett Syndrome

15-May-2014	Poster at International Meeting for Autism Research (IMFAR)
	Improving outcome measures for Rett Syndrome (RTT) clinical trials: the development of RTT-specific anchors for the Clinical Global Impression Scale

30-Sep-2013	Poster at 2013 FRAXA Investigators Meeting
	The Impact of NNZ-2591 on the fmr1 Knockout Mouse Model of Fragile X Syndrome

4-Apr-2013	Poster at American Neuropsychiatric Association 2013 Annual Meeting
	The Impact of NNZ-2566 on the fmr1 Knockout Mouse Model of Fragile X Syndrome

1-Aug-2012	Presentation by Dr Mike Snape at ICare4Autism 2012 International Autism Conference
	NNZ-2566 - Rationale for use in Autism Spectrum Disorders